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ABSTRACT
Primary left hepatic duct neuroendocrine tumors are extremely rare.We describe 2 cases of siblings, a 51-year-old brother and a 48-
year-old sister, who were both diagnosed with primary left hepatic duct neuroendocrine tumor. Both patients underwent successful
left hepatectomy and are both alive with no recurrence. For this rare malignancy, while definitive diagnosis is made only by
histopathology, a margin-free surgical resection remains the only curative treatment modality to date.
INTRODUCTION
Primary biliary tract neuroendocrine tumors (NETs) are rare with a range from 0.2% to 2% of all gastrointestinal NETs.1,2
The final diagnosis requires always the chromogranin A (CgA) determination with immunohistochemistry in the specimen.
A MEDLINE search for the literature has identified just 2 reports of NETs that arose clearly from within the right or
left hepatic duct, hereby intrahepatic bile ducts are the most uncommon site of neuroendocrine malignancy in the biliary
tract.
CASE REPORT
Case 1: A 48-year-old woman presented with abdominal pain mainly referred to the right upper quadrant. Her father had
prostate cancer. Physical examination revealed no remarkable findings. Abdominal ultrasonography (US) presented
a hyperechoic lesion measuring 4 cm in the left liver. Laboratory workup showed carbohydrate antigen 19-9 65.3 U/mL and
cancer antigen 72-4 17.70 U/mL, without any other abnormalities. Total body contrast computed tomography (CT) showed
a hypodense formation in the fourth hepatic segment with a thick peripheral portion, measuring 3.83 3.23 3 cm (Figure 1).
Abdominal contrast magnetic resonance imaging showed a lesion measuring 4 3 3 3 3.5 cm in the fourth hepatic segment
(Figure 2).
The patient underwent left hepatectomy with cholecystectomy. Intraoperative ultrasonography (USG) confirmed a lesion
arising from the left hepatic duct. The operation was successfully performed, and after an uneventful recovery, our patient was
discharged in good condition. Histopathology with immunohistochemistry reported NET cell appearance and positivity for
Pan-cytokeratin, low-molecular-weight cytokeratin, CgA, and cluster of differentiation 56 (CD 56), with a Ki67 index of,2%,
thus confirming diagnosis of NET G1 of the left hepatic duct. After 39 months of follow-up, included serial laboratory tests,
abdominal USG, chest and abdomen CT, and an octreotide scan scintigraphy, the patient had good health without recurrence
(Figure 3).
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Case 2: A 51-year-old man presented with vomiting and ab-
dominal pain to the right upper quadrant. The patient’s sister
had been diagnosed and operated for NETG1 of the left hepatic
duct, and his father had been diagnosed with prostatic cancer.
Laboratory workup revealed no remarkable findings. Abdom-
inal US showed a hyperechoic lesion measuring 6 3 7 cm in
the left liver. Abdominal CT and magnetic resonance imag-
ing confirmed a lesion in the left liver (Figure 4). Contrast-
enhanced ultrasound were suggestive for cholangiocarcinoma
with suspected involvement of the pancreaticoduodenal lymph
nodes.
The patient underwent left hepatectomy with cholecystec-
tomy and locoregional lymphadenectomy. Intraoperatively,
USG confirmed a lesion arising from the left hepatic duct.
The operation was successfully performed, and after an un-
eventful recovery, our patient was discharged in good condition.
Pathological examination with immunohistochemistry post-
operatively of the mass revealed NET cell appearance and
positivity for CgA, homeobox protein CDX-2, and so-
matostatin receptors-2A,5 with a Ki67 index of 2.3%, thus
confirming diagnosis of NET G1 of the left hepatic
duct. Three months after surgery, positron emission
tomography–68Ga-DOTANOC revealed hypercaptation
areas in proximity to the head of the pancreas, along the
pancreas body, and in proximity to the cutting surface of
the liver (Figure 5).
The patient was started on lanreotide treatment. Follow-up
endoscopic ultrasound confirmed highly vascularized for-
mation, of size 28 mm in contiguity to the head of the pan-
creas, suggesting a malignant duodenal NET with nodal
metastasis near the pancreas. After multidisciplinary
Figure 1. Contrast-enhanced arterial phase computed tomogra-
phy shows peripheral enhancement of the lesion suggesting ma-
lignancy (arrow).
Figure 2. Abdominal T2-weighted magnetic resonance imaging
shows a lesion with a hyperintense central portion, surrounded by
a mildly hyperintense peripheral portion.
Figure 3. Contrast-enhanced portal phase computed tomography
shows no tumor recurrence in the remnant right liver after left
hepatectomy.
Figure 4. Upper abdominal magnetic resonance imaging shows
a lesion measuring 7.7 3 7.1 cm in the left liver.
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discussions, the patient underwent total pancreasectomy
with splenectomy and hepatic resection. Intraoperative
extemporaneous analysis of the masses in contiguity to the
pancreas (head and body) confirmed them as metastatic
NET lymph nodes (Figure 6). The operation was successfully
performed, and after an uneventful recovery, our patient
was discharged in good condition. Histopathology of the
surgical specimen reported that the pancreas parenchyma
was tumor-free with 2 positive metastatic lymph nodes in
contiguity to the head and the body, the lesion in the liver
was chronic xanthogranulomatous inflammation mimick-
ing tumor nodule, and the duodenum was positive for
primitive multifocal NET G1 and partially positive for
gastrin (,30%).
DISCUSSION
Primary biliary tract NETs are rare, and intrahepatic bile
duct NETs are further rare, with only 2 cases reported in
the literature. In 1998, a right hepatic duct NET was di-
agnosed in a 74-year-old asymptomatic man as an incidental
finding and was successfully treated by surgery.3 In 2002,
a NET in the left hepatic duct was diagnosed in a 69-year-old
woman with right upper quadrant pain. Initially the tumor
was not resectable and somatostatin analogue was adminis-
tered with evidence of radiological tumor regression.4
We present the first case of 2 sibling patients, brother and
sister, whowere both diagnosedwith primary left hepatic duct
NET and were successfully treated by surgery with no local
recurrence. Although the presence of NETs in the sibling is
highly suspicious for hereditary endocrine syndrome, a ge-
netic test for multiple endocrine neoplasia type 1 resulted
negative.
Nevertheless, an unknown hereditary endocrine syndrome or
multiple endocrine neoplasia type 1 mutation could play a role
in the genesis of the 3 tumors (2 hepatic and 1 duodenal) in 2
siblings.
There are a small number of intrahepatic bile duct NET cases
reported in the literature, making it difficult to define a unique
treatment strategy. Our cases represent 50% of the world lit-
erature, and we urge consideration of radical removal of lesions
as a curative treatment.
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Figure 5. Positron emission tomography shows the hypercaptation area (A) in close proximity to the head of the pancreas and (B) in proximity
to the cutting surface of the liver.
Figure 6. Enlarged metastatic neuroendocrine tumor lymph node
near the pancreas head.
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